We are live on
!
Find out more
BSA
Braun Stacey Associates Portfolio holdings
AUM
$3.01B
1-Year Est. Return
47.79%
This Fund
S&P 500
This Quarter
Est. Return
+8.2%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$2.68B
AUM Growth
+$43.8M
(+1.7%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-2.88%
Top 10 Holdings %
Top 10 Hldgs %
33.94%
Holding
121
New
7
Increased
28
Reduced
73
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$19.5M |
| 2 |
Corcept Therapeutics
CORT
|
+$15.5M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$14M |
| 4 |
TG Therapeutics
TGTX
|
+$12.7M |
| 5 |
Encompass Health
EHC
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$24.9M |
| 2 |
Applovin
APP
|
+$23.4M |
| 3 |
Uber
UBER
|
+$22.7M |
| 4 |
IQVIA
IQV
|
+$11.8M |
| 5 |
Vertiv
VRT
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.33% |
| 2 | Financials | 13.75% |
| 3 | Communication Services | 12.62% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Healthcare | 10.13% |
Similar funds
CI
BGDI
ROTUOC
KIA
PCM
TAM
DIG
Braun Stacey Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Braun Stacey Associates held 121 positions worth $2.68B, up 1.7% from $2.63B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Braun Stacey Associates's Q4 2024 filing shows 7 new, 28 increased, 73 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 348,518 shares worth $19.7M. The largest sale was Merck, an estimated $24.9M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Communication Services.
- Braun Stacey Associates's largest Q4 2024 buy was Bristol-Myers Squibb: 348,518 shares worth $19.7M.
- Braun Stacey Associates added most to Targa Resources in Q4 2024, an estimated $10.2M increase.
- Braun Stacey Associates's biggest Q4 2024 reduction was Applovin, cutting an estimated $23.4M.
- Braun Stacey Associates fully exited Merck in Q4 2024, selling an estimated $24.9M.
- Braun Stacey Associates's ten largest holdings make up 34% of its $2.68B portfolio in Q4 2024.
- Braun Stacey Associates opened 7 new positions and closed 5 in Q4 2024.
- Braun Stacey Associates's portfolio value rose 1.7% quarter-over-quarter to $2.68B.
Based on Braun Stacey Associates's 13F filing for Q4 2024, filed 31 Jan 2025.